Roth Capital Downgrades China Cord Blood To Neutral

By: via Benzinga
Roth Capital downgraded China Cord Blood Corp (NYSE: CO) from Buy to Neutral. The price target for China Cord Blood has been raised ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.